Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RVLP | RVL Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2022 | Option Exercise | $1.13 | 9,607 | 10,856 | 141,473 | Jan 26, 2022, 04:31 PM | |
OSMT | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | May 18, 2021 | Option Exercise | $3.12 | 6,467 | 20,177 | 151,080 | May 20, 2021, 04:06 PM | |
OSMT | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 24, 2021 | Option Exercise | $4.46 | 9,668 | 43,119 | 157,547 | Jan 26, 2021, 07:02 PM | |
OSMT | Osmotica Pharmaceuticals plc | Einhorn Andrew J. | Chief Financial Officer | Jan 28, 2020 | Option Exercise | $7.00 | 9,184 | 64,288 | 95,665 | Jan 30, 2020, 05:38 PM | |
EDGE | Edge Therapeutics, Inc. | Einhorn Andrew J. | Chief Financial Officer | Mar 01, 2017 | Option Exercise | $2.39 | 1,567 | 3,745 | 43,223 | Mar 13, 2017, 01:47 PM | |
EDGE | Edge Therapeutics, Inc. | Einhorn Andrew J. | Chief Financial Officer | Oct 06, 2015 | Option Exercise | $6.79 | 2,377 | 16,140 | 41,656 | Oct 08, 2015, 04:13 PM | |
EDGE | Edge Therapeutics, Inc. | Einhorn Andrew J. | Chief Financial Officer | Oct 06, 2015 | Buy | $10.88 | 46,651 | 507,795 | 83,592 | Oct 08, 2015, 04:13 PM |